Clinical trials
Sjogren's Syndrome trials in France with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2017 | 1 |
| 2020 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Brest | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Centre Hospitalier Universitaire Dijon | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| University Hospital, Bordeaux | 1 |
| University Hospital, Clermont-Ferrand | 1 |
| University Hospital, Limoges | 1 |
| University Hospital, Montpellier | 1 |
| Université de Reims Champagne-Ardenne | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sjogren's Syndrome | 11 |
| Connective Tissue Diseases | 3 |
| Autoimmune Diseases | 2 |
| Scleroderma, Systemic | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Arthritis, Rheumatoid | 1 |
| Asthenia | 1 |
| Digestive System Abnormalities | 1 |
| Fatigue | 1 |
| HIV Infections | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.